Common Chemotherapy Drugs--Doxorubicin

Links shared publicly online about this topic.

  • 770
    total visits

Common Chemotherapy Drugs--Doxorubicin

suite101.com

Doxorubicin is a frequently prescribed chemotherapy drug. As with any chemotherapy, however, patients should know its pros and cons before treatment.

View full resource at suite101.com

Tags: Chemotherapy, Drug, Science

  • Share

Most Recently Shared on October 28, 2010 at 1:25 am By:

HealthPassion HealthPassion

Common Chemotherapy Drugs--Doxorubicin: Doxorubicin is a frequently prescribed chemotherapy drug. As with any chem... http://bit.ly/99jfjm

1 year ago...

David Casarett, M.D.: Overtreatment in Cancer: Common Sense Medicine

huffingtonpost.com — “ASCO's admonition to avoid ineffective treatment is unlikely to constrain the use of chemotherapy in advanced cancer significantly, because although it's good advice, it's difficult to put into practice.View full resource at huffingtonpost.com

  • View Related
  • Share

Most Recently Shared on April 9, 2012 at 9:12 pm By:

Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors - QualityPoint Technologies

qualitypointtech.net — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta. Principal investigator Ing Swie Goping and her team discovered some breast cancer tumours had low levels of certain genes, and that those tumours didn't respond well to taxane chemotherapy, a common treatment used in breast cancer.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 9:00 am By:

MedicalFeed MedicalFeed Health News Feed

Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors: Some breast cancer tumours may be resistant to a... http://t.co/djUq2Tr4

2 weeks ago...

Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors

medicalnewstoday.com — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.Principal investigator Ing Swie Goping and hView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 7:05 am By:

mnt_breastcance MNT Breast Cancer Health News

Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors http://t.co/878KL5xU #breastcancer

2 weeks ago...

Study: Some breast cancer tumours may not respond to taxane chemotherapy

news-medical.net — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 10:54 am By:

NewsMedical News-Medical.Net Health News

Study: Some breast cancer tumours may not respond to taxane chemotherapy: Some breast cancer tumours may be resi... http://t.co/TxedXJNW

3 weeks ago...

Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy

medicalnewstoday.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 8:05 am By:

LungCancer Lung Cancer OW OW Health

Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy: Non-small ... http://t.co/nfOz9EY5

4 weeks ago...

Double whammy: RNAi enhances lung cancer therapy

medicalxpress.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tyrosine kinase inhibitors (TKI). New research published in BioMed Central's open access journal BMC Medicine, ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 11:57 pm By:

physorg_health PhysOrg Health News Health News

Double whammy: RNAi enhances lung cancer therapy http://t.co/EN8Gv6zW

4 weeks ago...

Long-term cognitive effects seen with once-common breast chemotherapy regimen - ONA

oncologynurseadvisor.com — “Cognitive deficits subsequent to breast cancer chemotherapy using cyclophosphamide, methotrexate, and fluorouracil can be long-lasting.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 1:06 pm By:

Taking a pill to fight cancer? Avoid these dangerous drug interactions - Boston.com

bostonglobe.com — “Common cancer treatments nowadays include not just radiation, surgery, and infusion chemotherapy treatments, but also pills that patients take every day for weeks, months, or even years. Many ofView full resource at bostonglobe.com

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 1:41 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Taking a pill to fight cancer? Avoid these dangerous drug interactions - Boston Globe http://t.co/m19vtY6l #medicine

4 weeks ago...

Taking a pill to fight cancer? Avoid these dangerous drug interactions - Daily Dose: A Boston Globe blog with health news, advice, and information.

boston.com — “Cancer treatments nowadays include not just radiation, surgery, and infusion chemotherapy treatments, but also pills that patients take every day for weeks, months, or even years. Many of these pills, however, interact with common medications such as acid blockers and antihistamines, rendering the cancer drugs less effective or dangerously potent. The majority of cancer patients taking a particular kind of oral cancer drug, known as kinase inhibitors, were taking other medications that interacteView full resource at boston.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 10:21 pm By:

rlanzara Richard G. Lanzara Health Professional

Taking a pill to fight cancer? Avoid these dangerous drug interactions http://t.co/AWzTxPDn #healthcare #medicine #cancer

4 weeks ago...

Biology Researcher on the Verge of a Technological Breakthrough in Drug Creation Process | Biomarker Commons

biomarkercommons.org — “New technology being developed at Florida State University could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality health care and cancer patients receiving personalized chemotherapy treatments.View full resource at biomarkercommons.org

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 11:16 am By:

Study provides insight into developing new treatment strategies for triple-negative breast cancer

news-medical.net — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 6:48 am By:

NewsMedical News-Medical.Net Health News

Study provides insight into developing new treatment strategies for triple-negative breast cancer: A new study b... http://t.co/uDcJkXt5

1 month ago...

Are there certain things that make getting primary ovarian insufficiency more likely?

healthtap.com — “Chemotherapy, ovarian surgery, genetics, exposure to radiation would be the most common antecedants.View full resource at healthtap.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 3:34 am By:

DrOpsahl Michael Opsahl MD Surgeon, Reproductive Endocrinologist, Physician, Doctor, and ObGyn Physician

#HealthTap: Are there certain things that make getting primary ovarian insufficiency more likely? Answer http://t.co/VJzYADTn

1 month ago...

New study shows promise for developing new treatments for breast cancer

eurekalert.org — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 3:59 pm By:

BreastCancer_OW Breast Cancer OW OW Health

New study shows promise for developing new treatments for breast cancer: ( University of Kentucky ) A new study ... http://t.co/23ME1deZ

1 month ago...

New study shows promise for developing new treatments for breast cancer

medicalxpress.com — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 3:21 pm By:

physorg_health PhysOrg Health News Health News

New study shows promise for developing new treatments for breast cancer http://t.co/Q7JNTjZX

1 month ago...

Financial hardship common among colon cancer patients

medicalxpress.com — “(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March 12 in the Journal of Clinical Oncology.View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 7:47 pm By:

physorg_health PhysOrg Health News Health News

Financial hardship common among colon cancer patients http://t.co/9Di5WdIp

1 month ago...

Advertisement